Effect of N-Acetylcysteine on Cisplatin Toxicity: A Review of the Literature

References

• Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int, J, Cancer. 2019;144(8):1941–1953. doi:10.1002/ijc.31937
   PubMed Web of Science ®Google Scholar
• Al-Tonbary Y, Al-Haggar M, El-Ashry R, El-Dakroory S, Azzam H, Fouda A. Vitamin e and N-acetylcysteine as antioxidant adjuvant therapy in children with acute lymphoblastic leukemia. Adv Hematol. 2009;2009:689639. doi:10.1155/2009/689639
   PubMedGoogle Scholar
• Singh K, Bhori M, Kasu YA, Bhat G, Marar T. Antioxidants as precision weapons in war against cancer chemotherapy-induced toxicity - Exploring the armoury of obscurity. Saudi Pharm J. 2018;26(2):177–190. doi:10.1016/j.jsps.2017.12.013
   PubMed Web of Science ®Google Scholar
• Qi L, Luo Q, Zhang Y, Jia F, Zhao Y, Wang F. Advances in toxicological research of the anticancer drug cisplatin. Chem Res Toxicol. 2019;32(8):1469–1486. doi:10.1021/acs.chemrestox.9b00204
   PubMed Web of Science ®Google Scholar
• Raghu G, Berk M, Campochiaro PA, et al. The multifaceted therapeutic role of N-Acetylcysteine (NAC) in disorders characterized by oxidative stress. Curr Neuropharmacol. 2021;19(8):1202–1224. doi:10.2174/1570159X19666201230144109
   PubMed Web of Science ®Google Scholar
• Rogliani P, Matera MG, Page C, Puxeddu E, Cazzola M, Calzetta L. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine. Respir Res. 2019;20(1):104. doi:10.1186/s12931-019-1078-y
   PubMed Web of Science ®Google Scholar
• Calverley P, Rogliani P, Papi A. Safety of N-acetylcysteine at high doses in chronic respiratory diseases: a review. Drug Saf. 2021;44(3):273–290. doi:10.1007/s40264-020-01026-y
   PubMed Web of Science ®Google Scholar
• Bavarsad Shahripour R, Harrigan MR, Alexandrov AV. N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities. Brain Behav. 2014;4(2):108–122. doi:10.1002/brb3.208
   PubMed Web of Science ®Google Scholar
• Wahabi K, Perwez A, Rizvi MA. Antioxidant in Cancer. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Chakraborti S, eds. Singapore: Springer; 2022.
   Google Scholar
• Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol. 2014;24(10):R453–R462. doi:10.1016/j.cub.2014.03.034
   PubMed Web of Science ®Google Scholar
• Shi X, Zhang Y, Zheng J, Pan J. Reactive oxygen species in cancer stem cells. Antioxid Redox Signal. 2012;16(11):1215–1228. doi:10.1089/ars.2012.4529
   PubMed Web of Science ®Google Scholar
• Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem. 2015;97:55–74. doi:10.1016/j.ejmech.2015.04.040
   PubMed Web of Science ®Google Scholar
• Colovic MB, Vasic VM, Djuric DM, Krstic DZ. Sulphur-containing amino acids: protective role against free radicals and heavy metals. Curr Med Chem. 2018;25(3):324–335. doi:10.2174/0929867324666170609075434
   PubMed Web of Science ®Google Scholar
• He L, He T, Farrar S, Ji L, Liu T, Ma X. Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species. Cell Physiol Biochem. 2017;44(2):532–553. doi:10.1159/000485089
   PubMedGoogle Scholar
• Pisoschi AM, Pop A, Iordache F, Stanca L, Predoi G, Serban AI. Oxidative stress mitigation by antioxidants - An overview on their chemistry and influences on health status. Eur J Med Chem. 2021;209:112891. doi:10.1016/j.ejmech.2020.112891
   PubMed Web of Science ®Google Scholar
• Bansal A, Simon MC. Glutathione metabolism in cancer progression and treatment resistance. J Cell Biol. 2018;217(7):2291–2298. doi:10.1083/jcb.201804161
   PubMed Web of Science ®Google Scholar
• Kong H, Chandel NS. Regulation of redox balance in cancer and T cells. J Biol Chem. 2018;293(20):7499–7507. doi:10.1074/jbc.TM117.000257
   PubMed Web of Science ®Google Scholar
• Khan SU, Fatima K, Aisha S, Hamza B, Malik F. Redox balance and autophagy regulation in cancer progression and their therapeutic perspective. Med Oncol. 2022;40(1):12. doi:10.1007/s12032-022-01871-0
   PubMed Web of Science ®Google Scholar
• Moloney JN, Cotter TG. ROS signalling in the biology of cancer. Semin Cell Dev Biol. 2018;80:50–64. doi:10.1016/j.semcdb.2017.05.023
   PubMed Web of Science ®Google Scholar
• Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014;740:364–378. doi:10.1016/j.ejphar.2014.07.025
   PubMed Web of Science ®Google Scholar
• Ghosh SC. The first metal based anticancer drug. Bioorg Chem. 2019;88:102925. doi:10.1016/j.bioorg.2019.102925
   PubMed Web of Science ®Google Scholar
• Zhang J, Ye ZW, Tew KD, Townsend DM. Cisplatin chemotherapy and renal function. Adv Cancer Res. 2021;152:305–327. doi:10.1016/bs.acr.2021.03.008
   PubMed Web of Science ®Google Scholar
• Domingo IK, Latif A, Bhavsar AP. Pro-inflammatory signalling prropels cisplatin-induced toxicity. Int J Mol Sci. 2022;23(13):7227. doi:10.3390/ijms23137227
   PubMed Web of Science ®Google Scholar
• Abadi AJ, Mirzaei S, Mahabady MK, et al. Curcumin and its derivatives in cancer therapy: potentiating antitumor activity of cisplatin and reducing side effects. Phytother Res. 2022;36(1):189–213. doi:10.1002/ptr.7305
   PubMed Web of Science ®Google Scholar
• Sato K, Watanabe S, Ohtsubo A, et al. Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors. BMC Cancer. 2016;16(1):222. doi:10.1186/s12885-016-2271-8
   PubMedGoogle Scholar
• Finkel M, Goldstein A, Steinberg Y, Granowetter L, Trachtman H. Cisplatinum nephrotoxicity in oncology therapeutics: retrospective review of patients treated between 2005 and 2012. Pediatr Nephrol. 2014;29(12):2421–2424. doi:10.1007/s00467-014-2935-z
   PubMed Web of Science ®Google Scholar
• Holditch SJ, Brown CN, Lombardi AM, Nguyen KN, Edelstein CL. Recent advances in models, mechanisms, biomarkers, and interventions in cisplatin-induced acute kidney injury. Int J Mol Sci. 2019;20(12):3011. doi:10.3390/ijms20123011
   PubMed Web of Science ®Google Scholar
• Sancho-Martínez SM, Prieto-García L, Prieto M, et al. N-acetylcysteine transforms necrosis into apoptosis and affords tailored protection from cisplatin cytotoxicity. Toxicol Appl Pharmacol. 2018;349:83–93. doi:10.1016/j.taap.2018.04.010
   PubMed Web of Science ®Google Scholar
• Badr AM, Al-Kharashi LA, Attia H, et al. TLR4/inflammasomes cross-talk and pyroptosis contribute to N-Acetyl cysteine and chlorogenic acid protection against cisplatin-induced nephrotoxicity. Pharmaceuticals. 2023;16(3):337. doi:10.3390/ph16030337
   Web of Science ®Google Scholar
• Ramkumar V, Mukherjea D, Dhukhwa A, Rybak LP. Oxidative stress and inflammation caused by cisplatin ototoxicity. Antioxidants. 2021;10(12):1919. doi:10.3390/antiox10121919
   Web of Science ®Google Scholar
• Breglio AM, Rusheen AE, Shide ED, et al. Cisplatin is retained in the cochlea indefinitely following chemotherapy. Nat Commun. 2017;8(1):1654. doi:10.1038/s41467-017-01837-1
   PubMedGoogle Scholar
• Paken J, Govender CD, Pillay M, Sewram V. Cisplatin-associated ototoxicity: a review for the health professional. J Toxicol. 2016;2016:1809394. doi:10.1155/2016/1809394
   PubMed Web of Science ®Google Scholar
• Freyer DR, Brock P, Knight K, et al. Interventions for cisplatin-induced hearing loss in children and adolescents with cancer. Lancet Child Adolesc Health. 2019;3(8):578–584. doi:10.1016/S2352-4642(19)30115-4
   PubMedGoogle Scholar
• Gonçalves MS, Silveira AF, Teixeira AR, Hyppolito MA. Mechanisms of cisplatin ototoxicity: theoretical review. J Laryngol Otol. 2013;127(6):536–541. doi:10.1017/S0022215113000947
   PubMed Web of Science ®Google Scholar
• Chirtes F, Albu S. Prevention and restoration of hearing loss associated with the use of cisplatin. Biomed Res Int. 2014;2014:925485. doi:10.1155/2014/925485
   PubMed Web of Science ®Google Scholar
• Meijer AJM, Li KH, Brooks B, et al. The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments. Cancer. 2022;128(1):169–179. doi:10.1002/cncr.33848
   PubMed Web of Science ®Google Scholar
• Tang Q, Wang X, Jin H, et al. Cisplatin-induced ototoxicity: updates on molecular mechanisms and otoprotective strategies. Eur J Pharm Biopharm. 2021;163:60–71. doi:10.1016/j.ejpb.2021.03.008
   PubMed Web of Science ®Google Scholar
• Amptoulach S, Tsavaris N. Neurotoxicity caused by the treatment with platinum analogues. Chemother Res Pract. 2011;2011:843019. doi:10.1155/2011/843019
   PubMedGoogle Scholar
• Groen CM, Podratz JL, Pathoulas J, Staff N, Windebank AJ. Genetic reduction of mitochondria complex I subunits is protective against cisplatin-induced neurotoxicity in Drosophila. J Neurosci. 2022;42(5):922–937. doi:10.1523/JNEUROSCI.1479-20.2021
   PubMed Web of Science ®Google Scholar
• Johnson C, Pankratz VS, Velazquez AI, et al. Candidate pathway-based genetic association study of platinum and platinum-taxane related toxicity in a cohort of primary lung cancer patients. J Neurol Sci. 2015;349(1–2):124–128. doi:10.1016/j.jns.2014.12.041
   PubMed Web of Science ®Google Scholar
• Shirmanova MV, Druzhkova IN, Lukina MM, et al. Chemotherapy with cisplatin: insights into intracellular pH and metabolic landscape of cancer cells in vitro and in vivo. Sci Rep. 2017;7(1):8911. doi:10.1038/s41598-017-09426-4
   PubMed Web of Science ®Google Scholar
• Santos NAGD, Ferreira RS, Santos ACD. Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents. Food Chem Toxicol. 2020;136:111079. doi:10.1016/j.fct.2019.111079
   PubMed Web of Science ®Google Scholar
• Carozzi VA, Canta A, Chiorazzi A. Chemotherapy-induced peripheral neuropathy: what do we know about mechanisms? [published correction appears in Neurosci Lett. 2015 Jun 2;596():108]. Neurosci Lett. 2015;596:90–107. doi:10.1016/j.neulet.2014.10.014
   PubMed Web of Science ®Google Scholar
• Ciarimboli G. Membrane transporters as mediators of cisplatin side-effects. Anticancer Res. 2014;34(1):547–550.
   PubMedGoogle Scholar
• Kelley MR, Jiang Y, Guo C, Reed A, Meng H, Vasko MR. Role of the DNA base excision repair protein, APE1 in cisplatin, oxaliplatin, or carboplatin induced sensory neuropathy. PLoS One. 2014;9(9):e106485. doi:10.1371/journal.pone.0106485
   PubMed Web of Science ®Google Scholar
• Lu SC. Glutathione synthesis. Biochim Biophys Acta. 2013;1830(5):3143–3153. doi:10.1016/j.bbagen.2012.09.008
   PubMed Web of Science ®Google Scholar
• Kalyanaraman B. NAC, NAC, Knockin’ on Heaven’s door: interpreting the mechanism of action of N-acetylcysteine in tumor and immune cells [published online ahead of print, 2022 Oct 9]. Redox Biol. 2022;57:102497. doi:10.1016/j.redox.2022.102497
   PubMed Web of Science ®Google Scholar
• Kwon Y. Possible beneficial effects of N-acetylcysteine for treatment of triple-negative breast cancer. Antioxidants. 2021;10(2):169. doi:10.3390/antiox10020169
   Web of Science ®Google Scholar
• Rushworth GF, Megson IL. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. Pharmacol Ther. 2014;141(2):150–159. doi:10.1016/j.pharmthera.2013.09.006
   PubMed Web of Science ®Google Scholar
• Aldini G, Altomare A, Baron G, et al. N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why. Free Radic Res. 2018;52(7):751–762. doi:10.1080/10715762.2018.1468564
   PubMed Web of Science ®Google Scholar
• Tenório MCDS, Graciliano NG, Moura FA, Oliveira ACM, Goulart MOF. N-Acetylcysteine (NAC): impacts on human health. Antioxidants. 2021;10(6):967. doi:10.3390/antiox10060967
   Web of Science ®Google Scholar
• Radomska-Lesnniewska DM, Skopinski P. N-acetylcysteine as an anti-oxidant and anti-inflammatory drug and its some clinical applications. Centr Eur J Immunol. 2012;37:57–66.
   Web of Science ®Google Scholar
• Samuni Y, Goldstein S, Dean OM, Berk M. The chemistry and biological activities of N-acetylcysteine. Biochim Biophys Acta. 2013;1830(8):4117–4129. doi:10.1016/j.bbagen.2013.04.016
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab WM, Moussa FI, Saad NA. Synergistic protective effect of N-acetylcysteine and taurine against cisplatin-induced nephrotoxicity in rats. Drug Des Devel Ther. 2017;11:901–908. doi:10.2147/DDDT.S131316
   PubMed Web of Science ®Google Scholar
• Zhitkovich A. N-Acetylcysteine: antioxidant, aldehyde scavenger, and more. Chem Res Toxicol. 2019;32(7):1318–1319. doi:10.1021/acs.chemrestox.9b00152
   PubMed Web of Science ®Google Scholar
• Luczak MW, Zhitkovich A. Role of direct reactivity with metals in chemoprotection by N-acetylcysteine against chromium (VI), cadmium (II), and cobalt (II). Free Radic Biol Med. 2013;65:262–269. doi:10.1016/j.freeradbiomed.2013.06.028
   PubMed Web of Science ®Google Scholar
• Higashi T, Elmeligy E, Mai Y, et al. Glutathione and cysteines suppress cytotoxicity of gas phase of cigarette smoke by direct reacting with unsaturated carbonyl compounds in the gas phase. Biochem Biophys Res Commun. 2019;509(4):988–993. doi:10.1016/j.bbrc.2019.01.040
   PubMed Web of Science ®Google Scholar
• Okamoto A, Tanaka M, Sumi C, et al. The antioxidant N-acetyl cysteine suppresses lidocaine-induced intracellular reactive oxygen species production and cell death in neuronal SH-SY5Y cells. BMC Anesthesiol. 2016;16(1):104. doi:10.1186/s12871-016-0273-3
   PubMedGoogle Scholar
• Gao X, Lampraki EM, Al-Khalidi S, Qureshi MA, Desai R, Wilson JB. N-acetylcysteine (NAC) ameliorates Epstein-Barr virus latent membrane protein 1 induced chronic inflammation. PLoS One. 2017;12(12):e0189167. doi:10.1371/journal.pone.0189167
   PubMed Web of Science ®Google Scholar
• Adil M, Amin SS, Mohtashim M. N-acetylcysteine in dermatology. Indian J Dermatol Venereol Leprol. 2018;84(6):652–659. doi:10.4103/ijdvl.IJDVL_33_18
   PubMed Web of Science ®Google Scholar
• Zampieri LX, Silva-Almeida C, Rondeau JD, Sonveaux P. Mitochondrial Transfer in Cancer: a Comprehensive Review. Int J Mol Sci. 2021;22(6):3245. doi:10.3390/ijms22063245
   PubMed Web of Science ®Google Scholar
• Pasquier J, Guerrouahen BS, Al Thawadi H, et al. Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance. J Transl Med. 2013;11(1):94. doi:10.1186/1479-5876-11-94
   PubMedGoogle Scholar
• Chang JC, Chang HS, Wu YC, et al. Mitochondrial transplantation regulates antitumour activity, chemoresistance and mitochondrial dynamics in breast cancer. J Exp Clin Cancer Res. 2019;38(1):30. doi:10.1186/s13046-019-1028-z
   PubMedGoogle Scholar
• Burt R, Dey A, Aref S, et al. Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress. Blood. 2019;134(17):1415–1429. doi:10.1182/blood.2019001398
   PubMed Web of Science ®Google Scholar
• Wang J, Liu X, Qiu Y, et al. Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells. J Hematol Oncol. 2018;11(1):11. doi:10.1186/s13045-018-0554-z
   PubMedGoogle Scholar
• Liu D, Gao Y, Liu J, et al. Intercellular mitochondrial transfer as a means of tissue revitalization. Signal Transduct Target Ther. 2021;6(1):65. doi:10.1038/s41392-020-00440-z
   PubMed Web of Science ®Google Scholar
• Mistry JJ, Marlein CR, Moore JA, et al. ROS-mediated PI3K activation drives mitochondrial transfer from stromal cells to hematopoietic stem cells in response to infection. Proc Natl Acad Sci U S A. 2019;116(49):24610–24619. doi:10.1073/pnas.1913278116
   PubMed Web of Science ®Google Scholar
• Poljsak B, Milisav I. The role of antioxidants in cancer, friends or foes? Curr Pharm Des. 2018;24(44):5234–5244. doi:10.2174/1381612825666190123112647
   PubMed Web of Science ®Google Scholar
• Šalamon Š, Kramar B, Marolt TP, Poljšak B, Milisav I. Medical and dietary uses of N-Acetylcysteine. Antioxidants. 2019;8(5):111. doi:10.3390/antiox8050111
   Web of Science ®Google Scholar
• Monti D, Sotgia F, Whitaker-Menezes D, et al. Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in breast cancer. Semin Oncol. 2017;44(3):226–232. doi:10.1053/j.seminoncol.2017.10.001
   PubMed Web of Science ®Google Scholar
• Amini A, Masoumi-Moghaddam S, Ehteda A, Liauw W, Morris DL. Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: sequential and combination therapy of gastrointestinal cancer cells. Am J Cancer Res. 2016;6(2):350–369.
   PubMed Web of Science ®Google Scholar
• Feng H, Moriyama T, Ohuchida K, et al. N-acetyl cysteine induces quiescent-like pancreatic stellate cells from an active state and attenuates cancer-stroma interactions. J Exp Clin Cancer Res. 2021;40(1):133. doi:10.1186/s13046-021-01939-1
   PubMed Web of Science ®Google Scholar
• Jurkowska H, Wróbel M. Inhibition of human neuroblastoma cell proliferation by N-acetyl-L-cysteine as a result of increased sulfane sulfur level. Anticancer Res. 2018;38(9):5109–5113. doi:10.21873/anticanres.12831
   PubMed Web of Science ®Google Scholar
• Le Gal K, Ibrahim MX, Wiel C, et al. Antioxidants can increase melanoma metastasis in mice. Sci Transl Med. 2015;7(308):308re8. doi:10.1126/scitranslmed.aad3740
   PubMed Web of Science ®Google Scholar
• Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med. 2014;6(221):221ra15. doi:10.1126/scitranslmed.3007653
   PubMed Web of Science ®Google Scholar
• Muldoon LL, Wu YJ, Pagel MA, Neuwelt EA. N-acetylcysteine chemoprotection without decreased cisplatin antitumor efficacy in pediatric tumor models. J Neurooncol. 2015;121(3):433–440. doi:10.1007/s11060-014-1657-1
   PubMed Web of Science ®Google Scholar
• Güntürk I, Yazici C, Köse SK, Dağli F, Yücel B, Yay AH. The effect of N-acetylcysteine on inflammation and oxidative stress in cisplatin-induced nephrotoxicity: a rat model. Turk J Med Sci. 2019;49(6):1789–1799. doi:10.3906/sag-1903-225
   PubMed Web of Science ®Google Scholar
• Shalby AB, Assaf N, Ahmed HH. Possible mechanisms for N-acetyl cysteine and taurine in ameliorating acute renal failure induced by cisplatin in rats. Toxicol Mech Methods. 2011;21(7):538–546. doi:10.3109/15376516.2011.568985
   PubMed Web of Science ®Google Scholar
• Huang S, You J, Wang K, et al. N-Acetylcysteine attenuates cisplatin-induced acute kidney injury by inhibiting the C5a receptor. Biomed Res Int. 2019;2019:4805853. doi:10.1155/2019/4805853
   PubMed Web of Science ®Google Scholar
• Somdaş MA, Güntürk İ, Balcıoğlu E, Avcı D, Yazıcı C, Özdamar S. Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy. Braz J Otorhinolaryngol. 2020;86(1):30–37. doi:10.1016/j.bjorl.2018.08.002
   PubMed Web of Science ®Google Scholar
• Chen BC, Lin LJ, Lin YC, Lee CF, Hsu WC. Optimal N-acetylcysteine concentration for intratympanic injection to prevent cisplatin-induced ototoxicity in Guinea pigs. Acta Otolaryngol. 2022;142(2):127–131. doi:10.1080/00016489.2022.2038796
   PubMed Web of Science ®Google Scholar
• Mohan S, Smyth BJ, Namin A, Phillips G, Gratton MA. Targeted amelioration of cisplatin-induced ototoxicity in Guinea pigs. Otolaryngol Head Neck Surg. 2014;151(5):836–839. doi:10.1177/0194599814544877
   PubMed Web of Science ®Google Scholar
• Zaki SM, Mohamed EA, Motawie AG, Abdel Fattah S. N-acetylcysteine versus progesterone on the cisplatin-induced peripheral neurotoxicity. Folia Morphol. 2018;77(2):234–245. doi:10.5603/FM.a2017.0090
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab WM, Moussa FI. Neuroprotective effect of N-acetylcysteine against cisplatin-induced toxicity in rat brain by modulation of oxidative stress and inflammation. Drug Des Devel Ther. 2019;13:1155–1162. doi:10.2147/DDDT.S191240
   PubMed Web of Science ®Google Scholar
• Vukovic R, Kumburovic I, Joksimovic Jovic J, et al. N-Acetylcysteine protects against the anxiogenic response to cisplatin in rats. Biomolecules. 2019;9(12):892. doi:10.3390/biom9120892
   PubMed Web of Science ®Google Scholar
• Gunturk EE, Yucel B, Gunturk I, Yazici C, Yay A, Kose K. The effects of N-acetylcysteine on cisplatin-induced cardiotoxicity. Bratisl Lek Listy. 2019;120(6):423–428. doi:10.4149/BLL_2019_068
   PubMed Web of Science ®Google Scholar
• Rosic G, Selakovic D, Joksimovic J, et al. The effects of N-acetylcysteine on cisplatin-induced changes of cardiodynamic parameters within coronary autoregulation range in isolated rat hearts. Toxicol Lett. 2016;242:34–46. doi:10.1016/j.toxlet.2015.11.028
   PubMed Web of Science ®Google Scholar
• Coşkun Ö, Öztopuz Ö, Büyük B. Possible protective activity of n-acetyl cysteine against cisplatin-induced hepatotoxicity in rats. Mol Biol Rep. 2021;48(1):637–644. doi:10.1007/s11033-020-06111-0
   PubMed Web of Science ®Google Scholar
• Elsayed A, Elkomy A, Elkammar R, et al. Synergistic protective effects of lycopene and N-acetylcysteine against cisplatin-induced hepatorenal toxicity in rats. Sci Rep. 2021;11(1):13979. doi:10.1038/s41598-021-93196-7
   PubMed Web of Science ®Google Scholar
• Sarafraz Z, Ahmadi A, Daneshi A. Transtympanic injections of N-acetylcysteine and dexamethasone for prevention of cisplatin-induced ototoxicity: double blind randomized clinical trial. Int Tinnitus J. 2018;22(1):40–45. doi:10.5935/0946-5448.20180007
   PubMedGoogle Scholar
• Riga MG, Chelis L, Kakolyris S, et al. Transtympanic injections of N-acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacy. Am J Clin Oncol. 2013;36(1):1–6. doi:10.1097/COC.0b013e31822e006d
   PubMed Web of Science ®Google Scholar
• Orgel E, Knight KR, Chi YY, et al. Intravenous N-Acetylcysteine to prevent cisplatin-induced hearing loss in children: a nonrandomized controlled Phase I trial. Clin Cancer Res. 2023;29(13):2410–2418. doi:10.1158/1078-0432.CCR-23-0252
   PubMed Web of Science ®Google Scholar
• Yoo J, Hamilton SJ, Angel D, et al. Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients. Laryngoscope. 2014;124(3):E87–E94. doi:10.1002/lary.24360
   PubMed Web of Science ®Google Scholar